Skip to main content
Top
Published in: European Journal of Drug Metabolism and Pharmacokinetics 3/2014

Open Access 01-09-2014 | Short Communication

The influence of herbal medicine ursolic acid on the uptake of rosuvastatin mediated by OATP1B1*1a and *5

Authors: Wen Jin Hua, Wei Xiao Hua, Fu Yong Nan, Wang An Jiang, Chen Yan

Published in: European Journal of Drug Metabolism and Pharmacokinetics | Issue 3/2014

Login to get access

Abstract

Chinese herbal medicines such as hawthorn, salvia, etc., are frequently combined with statins so as to treat cardiovascular diseases more effectively. Chinese herbal medicines contain many kinds of active components, which may have drug–drug interactions with statins. This study aims to explore the effect and mechanism by which ursolic acid affects OATP1B1-mediated transport of rosuvastatin. This study will explore the effect of ursolic acid on OAPT1B1-mediated transport of rosuvastatin in the different cell systems. Given the genetic polymorphisms of OATP1B1, simultaneously, this study will further explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. When the concentration of ursolic acid was 1.8 and 18 µM, it showed that ursolic acid significantly inhibits the uptake of rosuvastatin in both OATP1B1*1a-HEK 293T cells and OATP1B1*5-HEK 293T cells. The reduction of OATP1B1*1a transport of rosuvastatin were 34.60 ± 2.99 and 66.08 ± 1.83 %, and for OATP1B1*5 were 34.27 ± 7.08 % and 66.95 ± 1.14 %. Inhibitory parameters of IC50 were 6.25 ± 0.42 and 6.07 ± 0.57 µM, respectively. This study suggests that ursolic acid can affect the uptake of rosuvastatin in hepatocytes by inhibiting the transport of OATP1B1, and gene mutation of OATP1B1 may cause different effects on its transport of rosuvastatin.
Literature
go back to reference Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D et al (1999) Identification of a novel gene family encoding human liver specific organic anion transporter LST21 [J]. J Biol Chem 274(24):17159–17163PubMedCrossRef Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D et al (1999) Identification of a novel gene family encoding human liver specific organic anion transporter LST21 [J]. J Biol Chem 274(24):17159–17163PubMedCrossRef
go back to reference Amanda O, Megan R, Bruno H (2012) The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol 52:135–151CrossRef Amanda O, Megan R, Bruno H (2012) The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol 52:135–151CrossRef
go back to reference Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRef
go back to reference Choi JH, Lee MG, Cho JY, Lee JE, Kim KH, Park K (2008) Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. Clin Pharmacol Ther 83(2):251–257PubMedCrossRef Choi JH, Lee MG, Cho JY, Lee JE, Kim KH, Park K (2008) Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. Clin Pharmacol Ther 83(2):251–257PubMedCrossRef
go back to reference Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS (2011) Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica 41(1):24–34PubMedCrossRef Choi MK, Shin HJ, Choi YL, Deng JW, Shin JG, Song IS (2011) Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica 41(1):24–34PubMedCrossRef
go back to reference Funk C (2008) The role of hepatic transporters in drug elimination. Expert Opin. Drug Metab Toxicol 4(4):363–379PubMedCrossRef Funk C (2008) The role of hepatic transporters in drug elimination. Expert Opin. Drug Metab Toxicol 4(4):363–379PubMedCrossRef
go back to reference Gui C, Obaidat A, Chaguturu R, Hagenbuch B (2010) Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1–8PubMedCentralPubMedCrossRef Gui C, Obaidat A, Chaguturu R, Hagenbuch B (2010) Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1–8PubMedCentralPubMedCrossRef
go back to reference Jemnitz K, Veres Z, Tugyi R, Vereczkey L (2010) Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes. Toxicol In Vitro 24(2):605–610PubMedCrossRef Jemnitz K, Veres Z, Tugyi R, Vereczkey L (2010) Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes. Toxicol In Vitro 24(2):605–610PubMedCrossRef
go back to reference Jia Y, Bhuiyan MJH, Jun HJ, Lee JH, Hoang MH, Lee HJ et al (2011) Ursolic acid is a PPAR-a agonist that regulates hepatic lipid metabolism. Bioorg Med Chem Lett 21(19):5876–5880PubMedCrossRef Jia Y, Bhuiyan MJH, Jun HJ, Lee JH, Hoang MH, Lee HJ et al (2011) Ursolic acid is a PPAR-a agonist that regulates hepatic lipid metabolism. Bioorg Med Chem Lett 21(19):5876–5880PubMedCrossRef
go back to reference Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K (2005) Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15 + C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 7:513–522CrossRef Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K (2005) Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15 + C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 7:513–522CrossRef
go back to reference Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS et al (2004) Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 74(22):2769–2779PubMedCrossRef Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS et al (2004) Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 74(22):2769–2779PubMedCrossRef
go back to reference Lin CC, Fan HY, Kuo CW, Pao LH (2012) Evaluation of Chinese-herbal-medicine-induced herb–drug interactions: focusing on organic anion transporter 1. Evid Based Complement Altern Med 2012:967182 Lin CC, Fan HY, Kuo CW, Pao LH (2012) Evaluation of Chinese-herbal-medicine-induced herb–drug interactions: focusing on organic anion transporter 1. Evid Based Complement Altern Med 2012:967182
go back to reference Liu CX, Yi XL, Si DY, Xiao XF, He X, Li YZ (2011) Herb-drug interactions involving drug metabolizing enzymes and transporters. Curr Drug Metab 12:835–849PubMedCrossRef Liu CX, Yi XL, Si DY, Xiao XF, He X, Li YZ (2011) Herb-drug interactions involving drug metabolizing enzymes and transporters. Curr Drug Metab 12:835–849PubMedCrossRef
go back to reference Mizuna N, Niwa T, Yotsumoto Y, Sugiyama Y (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461CrossRef Mizuna N, Niwa T, Yotsumoto Y, Sugiyama Y (2003) Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55:425–461CrossRef
go back to reference Muck W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S et al (1999) Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin Pharmacol Ther 65:251–261PubMedCrossRef Muck W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S et al (1999) Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin Pharmacol Ther 65:251–261PubMedCrossRef
go back to reference Nakanishi T, Tamai I (2012) Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs. Drug Metab Pharmacokinet 27(1):106–121PubMedCrossRef Nakanishi T, Tamai I (2012) Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs. Drug Metab Pharmacokinet 27(1):106–121PubMedCrossRef
go back to reference Neuvonen PJ (2010) Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs 11(3):323–332PubMed Neuvonen PJ (2010) Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs 11(3):323–332PubMed
go back to reference Niemi M (2007) Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8(7):787–802PubMedCrossRef Niemi M (2007) Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8(7):787–802PubMedCrossRef
go back to reference Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y et al (2002) Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 302:804–813PubMedCrossRef Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y et al (2002) Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 302:804–813PubMedCrossRef
go back to reference Satoshi K, Kazuya M, Yi W, Yuichi S (2008) Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Metab Dispos 36:2014–2023CrossRef Satoshi K, Kazuya M, Yi W, Yuichi S (2008) Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Metab Dispos 36:2014–2023CrossRef
go back to reference Seithel A, Eberl S, Singer K, Auge D, Heinkele G, Wolf NB, Dörje F, Fromm MF, König J (2007) The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Drug Dispos 35:779–786CrossRef Seithel A, Eberl S, Singer K, Auge D, Heinkele G, Wolf NB, Dörje F, Fromm MF, König J (2007) The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Drug Dispos 35:779–786CrossRef
go back to reference Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y (2003) Inhibition of transporter mediated hepatic uptake as a mechanism for drug–drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther 304:610–616PubMedCrossRef Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y (2003) Inhibition of transporter mediated hepatic uptake as a mechanism for drug–drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther 304:610–616PubMedCrossRef
go back to reference Sui SM, Wen JH, Li XH, Xiong YQ (2011) Effect of OATP1B1 521T>C heterogenesis on pharmacokinetic characteristics of rosuvastatin in Chinese volunteers. Yao Xue Xue Bao 46(6):695–700PubMed Sui SM, Wen JH, Li XH, Xiong YQ (2011) Effect of OATP1B1 521T>C heterogenesis on pharmacokinetic characteristics of rosuvastatin in Chinese volunteers. Yao Xue Xue Bao 46(6):695–700PubMed
go back to reference Tirona RG, Leake BF, Merino G, Kim RB (2001) Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669–35675PubMedCrossRef Tirona RG, Leake BF, Merino G, Kim RB (2001) Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669–35675PubMedCrossRef
go back to reference Toth PP, Dayspring TD (2011) Drug safety evaluation of rosuvastatin[J]. Expert Opin Drug Saf 10(6):969–986PubMedCrossRef Toth PP, Dayspring TD (2011) Drug safety evaluation of rosuvastatin[J]. Expert Opin Drug Saf 10(6):969–986PubMedCrossRef
go back to reference Wen JH, Xiong YQ (2011) The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. Eur J Drug Metab Pharmacokinet 36:205–211PubMedCrossRef Wen JH, Xiong YQ (2011) The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. Eur J Drug Metab Pharmacokinet 36:205–211PubMedCrossRef
go back to reference Wen JH, Wei XH, Hu JF (2012) The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins. Cardiovasc Ther 30:e234–e241CrossRef Wen JH, Wei XH, Hu JF (2012) The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins. Cardiovasc Ther 30:e234–e241CrossRef
go back to reference Xia YY, Wei GL, Si DY, Liu CG (2011) Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study. J Chromatogr B 879:219–224CrossRef Xia YY, Wei GL, Si DY, Liu CG (2011) Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study. J Chromatogr B 879:219–224CrossRef
go back to reference Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ (2006) Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males[J]. Clin Chim Acta 373:99–103PubMedCrossRef Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ (2006) Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males[J]. Clin Chim Acta 373:99–103PubMedCrossRef
Metadata
Title
The influence of herbal medicine ursolic acid on the uptake of rosuvastatin mediated by OATP1B1*1a and *5
Authors
Wen Jin Hua
Wei Xiao Hua
Fu Yong Nan
Wang An Jiang
Chen Yan
Publication date
01-09-2014
Publisher
Springer International Publishing
Published in
European Journal of Drug Metabolism and Pharmacokinetics / Issue 3/2014
Print ISSN: 0378-7966
Electronic ISSN: 2107-0180
DOI
https://doi.org/10.1007/s13318-014-0187-8

Other articles of this Issue 3/2014

European Journal of Drug Metabolism and Pharmacokinetics 3/2014 Go to the issue